Further inquiries can be directed to the related author
Further inquiries can be directed to the related author.. including dermatologic- and pulmonary-related adverse events [4, 5, 6]. Instances of infusion reactions following vedolizumab administration are uncommon. Only 5% of individuals receiving vedolizumab encounter an infusion-related reaction, much rarer than with anti-TNF [7, 8]. Here, we describe an atypical demonstration of an infusion reaction toward vedolizumab happening following long term maintenance therapy. Case Statement We present a case of a 67-year-old male having a past medical history positive for left-sided ulcerative colitis (UC) diagnosed at the age of 64 years. His history is also notable of chronic ischemic heart disease after coronary artery bypass surgery at the age Sitravatinib of 47 years and several percutaneous coronary interventions since. Since the last coronary treatment at the age of 63 years, his…